Metraipolis › archive › dc_25beb9cecb4e

Adherence to daily growth hormone therapy in Japan: real-world data from the Melon Nikki™ app and device — Europe PMC PMID:42232529

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/42232529
DOI: 10.1210/jendso/bvag113
License (as archived): solo-consultazione
Archived: 2026-11-02T05:43:32.764Z
SHA-256 of the archived text: 6b9a3329833b6a3e947eb2ab4b3811cf90ac5c7c31569ebc3473da700d013987
Stable URL of this page: https://metraipolis.com/documento/dc_25beb9cecb4e

How to cite

Adherence to daily growth hormone therapy in Japan: real-world data from the Melon Nikki™ app and device — Europe PMC PMID:42232529 — Europe PMC (en), https://europepmc.org/article/MED/42232529 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_25beb9cecb4e (Metraipolis archive dc_25beb9cecb4e, sha256 6b9a3329833b6a3e947eb2ab4b3811cf90ac5c7c31569ebc3473da700d013987)

BibTeX

@misc{dc25beb9cecb4e,
  title = {Adherence to daily growth hormone therapy in Japan: real-world data from the Melon Nikki™ app and device — Europe PMC PMID:42232529},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42232529},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_25beb9cecb4e; sha256 6b9a3329833b6a3e947eb2ab4b3811cf90ac5c7c31569ebc3473da700d013987},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42232529. Agents can read the archived copy with the MCP tool read_document.